Over 70% of small-molecule therapeutics emerging from today's discovery pipelines are too poorly water-soluble to enable adequate bioavailability after oral intake. This solubility problem greatly hinders drug development and ultimately prevents patients from accessing potentially life-saving treatments.
Harpago is dedicated to defeating low solubility through rigorous formulation design and development.
Company Details
- Employees
- 2
- Address
- Tech Lane Ghent Science Park 82, Ghent,oost-Vlaanderen 9052,belgium
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://www.harpagocdmo.com/
- Keywords
- Formulation Design, Formulation Development, Dosage Form Development, Pharmaceutical Development.
- HQ
- Ghent, Oost-Vlaanderen
Harpago Questions
Harpago's website is https://www.harpagocdmo.com/
Harpago's LinkedIn profile is https://be.linkedin.com/company/harpago
Harpago has
2 employees.
View email and phone details for 2
employees at Harpago.
Harpago's industry is
Pharmaceutical Manufacturing
Harpago's top competitors are
Confo Therapeutics,
Seranovo,
Qualiphar Nv,
Purna Pharmaceuticals,
Pse@utokyo,
Ardena,
Argenx,
Biovia,
Mrm Health,
Isabelle Laurier.
Harpago's categories are Pharmaceutical Manufacturing
